Cargando…
On the demand for telemedicine: Evidence from the COVID‐19 pandemic
Telemedicine can expand access to health care at relatively low cost. Historically, however, demand for telemedicine has remained low. Using administrative records and a difference‐in‐differences methodology, we estimate the change in demand for telemedicine experienced after the onset of the COVID‐...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324159/ https://www.ncbi.nlm.nih.gov/pubmed/35527351 http://dx.doi.org/10.1002/hec.4523 |
_version_ | 1784756738921070592 |
---|---|
author | Busso, Matias Gonzalez, Maria P. Scartascini, Carlos |
author_facet | Busso, Matias Gonzalez, Maria P. Scartascini, Carlos |
author_sort | Busso, Matias |
collection | PubMed |
description | Telemedicine can expand access to health care at relatively low cost. Historically, however, demand for telemedicine has remained low. Using administrative records and a difference‐in‐differences methodology, we estimate the change in demand for telemedicine experienced after the onset of the COVID‐19 epidemic and the imposition of mobility restrictions. We find that the number of telemedicine calls made during the pandemic increased by 230 percent compared to the pre‐pandemic period. The effects were mostly driven by older individuals with preexisting conditions who used the service for internal medicine consultations. The demand for telemedicine remained relatively high even after mobility restrictions were relaxed, which is consistent with telemedicine being an “experience good.” These results are a proof of concept for policy makers to use such relatively low‐cost medical consultations, made possible by new technologies, to provide needed expansion of access to health care. |
format | Online Article Text |
id | pubmed-9324159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93241592022-07-30 On the demand for telemedicine: Evidence from the COVID‐19 pandemic Busso, Matias Gonzalez, Maria P. Scartascini, Carlos Health Econ Research Articles Telemedicine can expand access to health care at relatively low cost. Historically, however, demand for telemedicine has remained low. Using administrative records and a difference‐in‐differences methodology, we estimate the change in demand for telemedicine experienced after the onset of the COVID‐19 epidemic and the imposition of mobility restrictions. We find that the number of telemedicine calls made during the pandemic increased by 230 percent compared to the pre‐pandemic period. The effects were mostly driven by older individuals with preexisting conditions who used the service for internal medicine consultations. The demand for telemedicine remained relatively high even after mobility restrictions were relaxed, which is consistent with telemedicine being an “experience good.” These results are a proof of concept for policy makers to use such relatively low‐cost medical consultations, made possible by new technologies, to provide needed expansion of access to health care. John Wiley and Sons Inc. 2022-05-08 2022-07 /pmc/articles/PMC9324159/ /pubmed/35527351 http://dx.doi.org/10.1002/hec.4523 Text en © 2022 The Authors. Health Economics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Busso, Matias Gonzalez, Maria P. Scartascini, Carlos On the demand for telemedicine: Evidence from the COVID‐19 pandemic |
title | On the demand for telemedicine: Evidence from the COVID‐19 pandemic |
title_full | On the demand for telemedicine: Evidence from the COVID‐19 pandemic |
title_fullStr | On the demand for telemedicine: Evidence from the COVID‐19 pandemic |
title_full_unstemmed | On the demand for telemedicine: Evidence from the COVID‐19 pandemic |
title_short | On the demand for telemedicine: Evidence from the COVID‐19 pandemic |
title_sort | on the demand for telemedicine: evidence from the covid‐19 pandemic |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324159/ https://www.ncbi.nlm.nih.gov/pubmed/35527351 http://dx.doi.org/10.1002/hec.4523 |
work_keys_str_mv | AT bussomatias onthedemandfortelemedicineevidencefromthecovid19pandemic AT gonzalezmariap onthedemandfortelemedicineevidencefromthecovid19pandemic AT scartascinicarlos onthedemandfortelemedicineevidencefromthecovid19pandemic |